Campbell Newman Asset Management’s Medifast MED Stock Holding History

Campbell Newman Asset Management’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-14,760	Closed	-$1.7M	–	112
2022 Q4	$1.7M	Sell	14,760 -333	-2%	-$38.8K	0.17%	59
2022 Q3	$1.64M	Buy	15,093 +283	+2%	+$40.6K	0.18%	56
2022 Q2	$2.67M	Buy	14,810 +491	+3%	+$87.8K	0.28%	39
2022 Q1	$2.44M	Buy	14,319 +219	+2%	+$41.3K	0.24%	46
2021 Q4	$2.95M	Buy	14,100 +277	+2%	+$57.3K	0.26%	42
2021 Q3	$2.66M	Buy	13,823 +518	+4%	+$127K	0.27%	47
2021 Q2	$3.77M	Sell	13,305 -6	-0%	-$1.63K	0.37%	42
2021 Q1	$2.82M	Buy	13,311 +110	+0.8%	+$26.3K	0.3%	44
2020 Q4	$2.59M	Buy	13,201 +4,668	+55%	+$825K	0.29%	47
2020 Q3	$1.4M	Buy	8,533 +166	+2%	+$27.3K	0.18%	58
2020 Q2	$1.16M	Buy	8,367 +86	+1%	+$7.9K	0.16%	59
2020 Q1	$518K	Sell	8,281 -391	-5%	-$35.6K	0.09%	81
2019 Q4	$950K	Sell	8,672 -13	-0.1%	-$1.26K	0.13%	72
2019 Q3	$900K	Buy	8,685 +4,029	+87%	+$433K	0.13%	70
2019 Q2	$597K	Buy	4,656 +313	+7%	+$43.5K	0.09%	94
2019 Q1	$554K	Buy	+4,343	New	+$551K	0.09%	100

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Campbell Newman Asset Management's MED Position: Q1 2023 in Review

Campbell Newman Asset Management sold out of Medifast (MED) in Q1 2023, closing a stake of 14,760 shares — an estimated $1.7M sold.

Campbell Newman Asset Management first reported a position in MED in Q1 2019 and held it in 16 quarters. The position peaked at $3.77M in Q2 2021. 267 funds tracked by Wall St. Rank hold MED as of Q1 2023.

Campbell Newman Asset Management reported no remaining Medifast position as of Q1 2023 after selling out during the quarter.
Campbell Newman Asset Management sold 14,760 Medifast shares in Q1 2023, an estimated $1.7M.
Campbell Newman Asset Management first reported a position in Medifast in Q1 2019 and held it in 16 quarters.
Campbell Newman Asset Management's Medifast position peaked at $3.77M in Q2 2021.
267 funds tracked by Wall St. Rank held Medifast as of Q1 2023.

Based on Campbell Newman Asset Management's 13F filing for Q1 2023, filed 28 Apr 2023.